Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gervaise Moine

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2010
Cell surface heparan sulfate proteoglycans influence MHC class II-restricted antigen presentationMichel Léonetti, Adeline Gadzinski, Gervaise Moine
Vaccine|July 18, 2009
Cynomolgus macaques immunized with two HIV-1 Tat stabilized proteins raise strong and long-lasting immune responses with a pattern of Th1/Th2 response differing from that in miceSabrina Turbant, Frédéric Martinon, Gervaise Moine, et al.
The Journal of Biological Chemistry|September 15, 2004
Antigen stability controls antigen presentationRobert Thai, Gervaise Moine, Michel Desmadril, et al.
Vaccine|April 9, 2008
Increasing the humoral immunogenic properties of the HIV-1 Tat protein using a ligand-stabilizing strategyAlain Lecoq, Gervaise Moine, Laurent Bellanger, et al.
The Journal of Biological Chemistry|December 3, 2005
HIV-1 Tat raises an adjuvant-free humoral immune response controlled by its core region and its ability to form cysteine-mediated oligomersJongrak Kittiworakarn, Alain Lecoq, Gervaise Moine, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2010
Cell surface heparan sulfate proteoglycans influence MHC class II-restricted antigen presentationMichel Léonetti, Adeline Gadzinski, Gervaise Moine
Vaccine|July 18, 2009
Cynomolgus macaques immunized with two HIV-1 Tat stabilized proteins raise strong and long-lasting immune responses with a pattern of Th1/Th2 response differing from that in miceSabrina Turbant, Frédéric Martinon, Gervaise Moine, et al.
The Journal of Biological Chemistry|September 15, 2004
Antigen stability controls antigen presentationRobert Thai, Gervaise Moine, Michel Desmadril, et al.
Vaccine|April 9, 2008
Increasing the humoral immunogenic properties of the HIV-1 Tat protein using a ligand-stabilizing strategyAlain Lecoq, Gervaise Moine, Laurent Bellanger, et al.
The Journal of Biological Chemistry|December 3, 2005
HIV-1 Tat raises an adjuvant-free humoral immune response controlled by its core region and its ability to form cysteine-mediated oligomersJongrak Kittiworakarn, Alain Lecoq, Gervaise Moine, et al.
Pageof 1